Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 16, 2006. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification regarding insider share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transactions by Mr. J Clarke on February 9, 2006:
- Exercise of Options: Exercise of nil-price options over 8,103 Ordinary shares granted on February 15, 2002, under the SmithKline Beecham Mid-Term Incentive Plan (MTIP). These shares resulted from the deferral of an award made on October 28, 1998.
- Sale of Shares: Sale of 3,323 Ordinary shares at a price of GBP 14.98 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions.
Investor Verification Points
- Verify the total number of shares held by Mr. J Clarke following the exercise of 8,103 options and the sale of 3,323 shares.
- Confirm the market price of GlaxoSmithKline plc shares on February 9, 2006, to contextualize the sale price of GBP 14.98.
- Review the terms of the SmithKline Beecham Mid-Term Incentive Plan (MTIP) regarding the deferral of awards from 1998.